Vincere Biobank Research Protocol
Launched by VINCERE CANCER CENTER · Jul 12, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Vincere Biobank Research Protocol is a clinical trial focused on collecting biological samples, like blood, urine, and tissue, from people to help advance research in cancer treatment and care. By gathering these samples along with medical information, the study aims to improve how we screen for, treat, and manage cancer in patients.
To participate, you need to be at least 18 years old and able to provide a sample, as well as give your consent to be part of the study. This trial is open to everyone, regardless of gender. If you choose to join, you will be contributing to important research that could help many people affected by cancer in the future. The study is currently looking for participants, so if you meet the requirements and are interested, you may want to learn more about how you can help.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older; any gender
- • Able to donate a blood, urine, tissue, and/or other biospecimen sample
- • Able to provide informed consent to participate in the study
- Exclusion Criteria:
- • Minors, under the age of 18 years
- • Individuals who lack the capacity to give informed consent
About Vincere Cancer Center
Vincere Cancer Center is a leading clinical research organization dedicated to advancing cancer treatment through innovative clinical trials and cutting-edge therapies. Committed to enhancing patient outcomes, Vincere Cancer Center collaborates with top-tier researchers and healthcare professionals to explore novel therapeutic approaches and improve existing treatment modalities. With a focus on personalized medicine, the center aims to empower patients by providing access to the latest advancements in cancer care while maintaining the highest standards of safety and ethics in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Patients applied
Trial Officials
Vershalee Shukla, MD
Principal Investigator
Vincere Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported